{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:40:09Z","timestamp":1790016009925,"version":"4.0.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T00:00:00Z","timestamp":1543536000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000050","name":"U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K23 HL133438"],"award-info":[{"award-number":["K23 HL133438"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01 HL089897"],"award-info":[{"award-number":["U01 HL089897"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"U.S. Department of Health &amp; Human Services | NIH | National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["U01 HL089856"],"award-info":[{"award-number":["U01 HL089856"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    The diagnosis of chronic obstructive pulmonary disease (COPD) relies on demonstration of airflow obstruction. Traditional spirometric indices miss a number of subjects with respiratory symptoms or structural lung disease on imaging. We hypothesized that utilizing all data points on the expiratory spirometry curves to assess their shape will improve detection of mild airflow obstruction and structural lung disease. We analyzed spirometry data of 8307 participants enrolled in the COPDGene study, and derived metrics of airflow obstruction based on the shape on the volume-time (Parameter D), and flow-volume curves (Transition Point and Transition Distance). We tested associations of these parameters with CT measures of lung disease, respiratory morbidity, and mortality using regression analyses. There were significant correlations between FEV\n                    <jats:sub>1<\/jats:sub>\n                    \/FVC with Parameter D (r\u2009=\u2009\u22120.83; p\u2009&lt;\u20090.001), Transition Point (r\u2009=\u20090.69; p\u2009&lt;\u20090.001), and Transition Distance (r\u2009=\u20090.50; p\u2009&lt;\u20090.001). All metrics had significant associations with emphysema, small airway disease, dyspnea, and respiratory-quality of life (p\u2009&lt;\u20090.001). The highest quartile for Parameter D was independently associated with all-cause mortality (adjusted HR 3.22,95% CI 2.42\u20134.27; p\u2009&lt;\u20090.001) but a substantial number of participants in the highest quartile were categorized as GOLD 0 and 1 by traditional criteria (1.8% and 33.7%). Parameter D identified an additional 9.5% of participants with mild or non-recognized disease as abnormal with greater burden of structural lung disease compared with controls. The data points on the flow-volume and volume-time curves can be used to derive indices of airflow obstruction that identify additional subjects with disease who are deemed to be normal by traditional criteria.\n                  <\/jats:p>","DOI":"10.1038\/s41598-018-35930-2","type":"journal-article","created":{"date-parts":[[2018,11,26]],"date-time":"2018-11-26T12:30:12Z","timestamp":1543235412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["New Spirometry Indices for Detecting Mild Airflow Obstruction"],"prefix":"10.1038","volume":"8","author":[{"given":"Surya P.","family":"Bhatt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirav R.","family":"Bhakta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla G.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Barjaktarevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Bodduluri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young-il","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Eberlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prescott G.","family":"Woodruff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank C.","family":"Sciurba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J.","family":"Castaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MeiLan K.","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark T.","family":"Dransfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0987-4834","authenticated-orcid":false,"given":"Arie","family":"Nakhmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,11,30]]},"reference":[{"key":"35930_CR1","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1164\/rccm.201204-0596PP","volume":"187","author":"J Vestbo","year":"2013","unstructured":"Vestbo, J. et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187, 347\u2013365 (2013).","journal-title":"Am J Respir Crit Care Med"},{"key":"35930_CR2","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1001\/jamainternmed.2015.2735","volume":"175","author":"EA Regan","year":"2015","unstructured":"Regan, E. A. et al. Clinical and Radiologic Disease in Smokers With Normal Spirometry. JAMA Intern Med 175, 1539\u20131549 (2015).","journal-title":"JAMA Intern Med"},{"key":"35930_CR3","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMoa1505971","volume":"374","author":"PG Woodruff","year":"2016","unstructured":"Woodruff, P. G. et al. Clinical Significance of Symptoms in Smokers with Preserved Pulmonary Function. N Engl J Med 374, 1811\u20131821 (2016).","journal-title":"N Engl J Med"},{"key":"35930_CR4","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1080\/15412550601168358","volume":"4","author":"A Lindberg","year":"2007","unstructured":"Lindberg, A. et al. Decline in FEV1 in relation to incident chronic obstructive pulmonary disease in a cohort with respiratory symptoms. Copd 4, 5\u201313 (2007).","journal-title":"Copd"},{"key":"35930_CR5","doi-asserted-by":"crossref","unstructured":"Bhatt, S. P. et al. CT-derived Biomechanical Metrics Improve Agreement Between Spirometry and Emphysema. Acad Radiol (2016).","DOI":"10.1016\/j.acra.2016.02.002"},{"key":"35930_CR6","first-page":"565","volume":"46","author":"YK Tien","year":"1979","unstructured":"Tien, Y. K., Elliott, E. A. & Mead, J. Variability of the configuration of maximum expiratory flow-volume curves. J Appl Physiol Respir Environ Exerc Physiol 46, 565\u2013570 (1979).","journal-title":"J Appl Physiol Respir Environ Exerc Physiol"},{"key":"35930_CR7","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1164\/ajrccm\/136.1.108","volume":"136","author":"CR O\u2019Donnell","year":"1987","unstructured":"O\u2019Donnell, C. R. et al. Accuracy of spirometric and flow-volume indices obtained by digitizing volume-time tracings. Am Rev Respir Dis 136, 108\u2013112 (1987).","journal-title":"Am Rev Respir Dis"},{"key":"35930_CR8","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1378\/chest.98.3.643","volume":"98","author":"CR O\u2019Donnell","year":"1990","unstructured":"O\u2019Donnell, C. R. & Rose, R. M. The flow-ratio index. An approach for measuring the influence of age and cigarette smoking on maximum expiratory flow-volume curve configuration. Chest 98, 643\u2013646 (1990).","journal-title":"Chest"},{"key":"35930_CR9","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4187\/respcare.06510040","volume":"51","author":"CJ Zheng","year":"2006","unstructured":"Zheng, C. J., Adams, A. B., McGrail, M. P., Marini, J. J. & Greaves, I. A. A proposed curvilinearity index for quantifying airflow obstruction. Respir Care 51, 40\u201345 (2006).","journal-title":"Respir Care"},{"key":"35930_CR10","doi-asserted-by":"publisher","first-page":"797495","DOI":"10.1155\/2012\/797495","volume":"2012","author":"A Ohwada","year":"2012","unstructured":"Ohwada, A. & Takahashi, K. Concave pattern of a maximal expiratory flow-volume curve: a sign of airflow limitation in adult bronchial asthma. Pulm Med 2012, 797495 (2012).","journal-title":"Pulm Med"},{"key":"35930_CR11","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1002\/ppul.23112","volume":"50","author":"V Neve","year":"2015","unstructured":"Neve, V., Edme, J. L., Baquet, G. & Matran, R. Reference ranges for shape indices of the flow-volume loop of healthy children. Pediatr Pulmonol 50, 1017\u20131024 (2015).","journal-title":"Pediatr Pulmonol"},{"key":"35930_CR12","doi-asserted-by":"crossref","unstructured":"Li, H., Liu, C., Zhang, Y. & Xiao, W. The Concave Shape of the Forced Expiratory Flow-Volume Curve in 3 Seconds Is a Practical Surrogate of FEV1\/FVC for the Diagnosis of Airway Limitation in Inadequate Spirometry. Respir Care (2016).","DOI":"10.4187\/respcare.05016"},{"key":"35930_CR13","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.resp.2016.08.005","volume":"234","author":"J Varga","year":"2016","unstructured":"Varga, J. et al. Relation of concavity in the expiratory flow-volume loop to dynamic hyperinflation during exercise in COPD. Respir Physiol Neurobiol 234, 79\u201384 (2016).","journal-title":"Respir Physiol Neurobiol"},{"key":"35930_CR14","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1378\/chest.94.4.799","volume":"94","author":"MC Kapp","year":"1988","unstructured":"Kapp, M. C., Schachter, E. N., Beck, G. J., Maunder, L. R. & Witek, T. J. Jr. The shape of the maximum expiratory flow volume curve. Chest 94, 799\u2013806 (1988).","journal-title":"Chest"},{"key":"35930_CR15","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.2147\/COPD.S118415","volume":"11","author":"W Wang","year":"2016","unstructured":"Wang, W., Xie, M., Dou, S., Cui, L. & Xiao, W. Computer quantification of \u201cangle of collapse\u201d on maximum expiratory flow volume curve for diagnosing asthma-COPD overlap syndrome. Int J Chron Obstruct Pulmon Dis 11, 3015\u20133022 (2016).","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"35930_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3109\/15412550903499522","volume":"7","author":"EA Regan","year":"2010","unstructured":"Regan, E. A. et al. Genetic epidemiology of COPD (COPDGene) study design. Copd 7, 32\u201343 (2010).","journal-title":"Copd"},{"key":"35930_CR17","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1183\/09031936.05.00035205","volume":"26","author":"R Pellegrino","year":"2005","unstructured":"Pellegrino, R. et al. Interpretative strategies for lung function tests. Eur Respir J 26, 948\u2013968 (2005).","journal-title":"Eur Respir J"},{"key":"35930_CR18","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1038\/nm.2971","volume":"18","author":"CJ Galban","year":"2012","unstructured":"Galban, C. J. et al. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nature medicine 18, 1711\u20131715 (2012).","journal-title":"Nature medicine"},{"key":"35930_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1513\/AnnalsATS.201308-251OC","volume":"11","author":"SP Bhatt","year":"2014","unstructured":"Bhatt, S. P. et al. FEV(1)\/FEV(6) to diagnose airflow obstruction. Comparisons with computed tomography and morbidity indices. Ann Am Thorac Soc 11, 335\u2013341 (2014).","journal-title":"Ann Am Thorac Soc"},{"key":"35930_CR20","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","volume":"195","author":"CF Vogelmeier","year":"2017","unstructured":"Vogelmeier, C. F. et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med 195, 557\u2013582 (2017).","journal-title":"Am J Respir Crit Care Med"},{"key":"35930_CR21","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1164\/rccm.201101-0021OC","volume":"184","author":"ES Wan","year":"2011","unstructured":"Wan, E. S. et al. Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med 184, 57\u201363 (2011).","journal-title":"Am J Respir Crit Care Med"},{"key":"35930_CR22","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1164\/ajrccm.159.1.9712108","volume":"159","author":"JL Hankinson","year":"1999","unstructured":"Hankinson, J. L., Odencrantz, J. R. & Fedan, K. B. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 159, 179\u2013187 (1999).","journal-title":"Am J Respir Crit Care Med"},{"key":"35930_CR23","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s12931-015-0252-0","volume":"16","author":"M Topalovic","year":"2015","unstructured":"Topalovic, M. et al. Airways resistance and specific conductance for the diagnosis of obstructive airways diseases. Respir Res 16, 88 (2015).","journal-title":"Respir Res"},{"key":"35930_CR24","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1183\/13993003.02377-2014","volume":"46","author":"BG Harvey","year":"2015","unstructured":"Harvey, B. G. et al. Risk of COPD with obstruction in active smokers with normal spirometry and reduced diffusion capacity. Eur Respir J 46, 1589\u20131597 (2015).","journal-title":"Eur Respir J"},{"key":"35930_CR25","first-page":"409","volume":"69","author":"SP Bhatt","year":"2014","unstructured":"Bhatt, S. P. et al. Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax 69, 409\u2013414 (2014).","journal-title":"Thorax"},{"key":"35930_CR26","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.chest.2016.06.047","volume":"150","author":"AG Dilektasli","year":"2016","unstructured":"Dilektasli, A. G. et al. A Novel Spirometric Measure Identifies Mild COPD Unidentified by Standard Criteria. Chest 150, 1080\u20131090 (2016).","journal-title":"Chest"},{"key":"35930_CR27","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1378\/chest.69.1.51","volume":"69","author":"HP Saltzman","year":"1976","unstructured":"Saltzman, H. P., Ciulla, E. M. & Kuperman, A. S. The spirographic \u201ckink\u201d. A sign of emphysema. Chest 69, 51\u201355 (1976).","journal-title":"Chest"},{"key":"35930_CR28","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/1465-9921-14-131","volume":"14","author":"M Topalovic","year":"2013","unstructured":"Topalovic, M. et al. Computer quantification of airway collapse on forced expiration to predict the presence of emphysema. Respir Res 14, 131 (2013).","journal-title":"Respir Res"},{"key":"35930_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.resp.2015.08.002","volume":"219","author":"PB Dominelli","year":"2015","unstructured":"Dominelli, P. B. et al. Quantifying the shape of the maximal expiratory flow-volume curve in mild COPD. Respir Physiol Neurobiol 219, 30\u201335 (2015).","journal-title":"Respir Physiol Neurobiol"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35930-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35930-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35930-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T06:01:19Z","timestamp":1775282479000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-35930-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,30]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["35930"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-35930-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,30]]},"assertion":[{"value":"28 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 November 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Dr. Bhatt reports grants from NIH, other from ProterixBio, personal fees from Sunovion, during the conduct of the study; Dr. Barjaktarevic reports personal fees from Astra Zeneca, grants from GE Healthcare, personal fees from Grifols, personal fees from CSL Behring, grants from Amgen, grants from PCORI, outside the submitted work; Dr. Castaldi reports personal fees from GSK, from null, outside the submitted work; Dr. Cooper reports grants from Equinox Health Clubs, personal fees from Equinox Health Clubs, grants from Amgen, personal fees from PulmonX, other from GlaxoSmithKline, outside the submitted work; Dr. Dransfield reports grants from NHLBI, during the conduct of the study; grants from Department of Defense, personal fees and other from Boehringer Ingeheim, personal fees and other from GlaxoSmithKline, other from Novartis, personal fees and other from AstraZeneca, other from Yungjin, other from PneumRx\/BTG, other from Pulmonx, personal fees from Genentech, personal fees and other from Boston Scientific, outside the submitted work; Dr. Eberlein reports receiving consultancy fees from VIDA, Coralville IA, outside the submitted work; Dr. Han reports personal fees from GSK, personal fees from BI, personal fees from AstraZeneca, non-financial support from Novartis, non-financial support from Sunovion, outside the submitted work; Dr. Woodruff reports personal fees from Astra-Zeneca, personal fees from Theravance, personal fees from Regeneron, personal fees from Sanofi, personal fees from Genentech, personal fees from Novartis, personal fees from Janssen, outside the submitted work; All other authors do not report any potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17484"}}